Skip to content
10-Q

Quarterly Report

BIOMARIN PHARMACEUTICAL INC BMRN

0001048477-25-000107

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 23, 2025 192.11M sh
Shares Diluted Q3 2025 · Sep 30, 2025 192.03M sh
Shares Diluted Q3 2025 · Sep 30, 2025 196.89M sh
Shares Diluted Q3 2025 · Sep 30, 2024 197.15M sh
Shares Diluted Q3 2025 · Sep 30, 2024 196.68M sh
Capex Q3 2025 · Sep 30, 2025 $62.32M
Capex Q3 2025 · Sep 30, 2024 $65.89M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $728.35M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $387.21M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.25B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $942.84M
Stockholders Equity Q3 2025 · Sep 30, 2025 $6.06B
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.03B
Stockholders Equity Q3 2025 · Dec 31, 2024 $5.66B
Stockholders Equity Q3 2025 · Sep 30, 2024 $5.41B
Stockholders Equity Q3 2025 · Jun 30, 2024 $5.29B
Stockholders Equity Q3 2025 · Dec 31, 2023 $4.95B
Current Liabilities Q3 2025 · Sep 30, 2025 $798.44M
Current Liabilities Q3 2025 · Dec 31, 2024 $606.99M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.56B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.33B
Current Assets Q3 2025 · Sep 30, 2025 $3.85B
Current Assets Q3 2025 · Dec 31, 2024 $3.23B
Total Assets Q3 2025 · Sep 30, 2025 $7.61B
Total Assets Q3 2025 · Dec 31, 2024 $6.99B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.16
Eps Diluted Q3 2025 · Sep 30, 2025 $2.04
Eps Diluted Q3 2025 · Sep 30, 2024 $0.55
Eps Diluted Q3 2025 · Sep 30, 2024 $1.56
Eps Basic Q3 2025 · Sep 30, 2025 −$0.16
Eps Basic Q3 2025 · Sep 30, 2025 $2.06
Eps Basic Q3 2025 · Sep 30, 2024 $0.56
Eps Basic Q3 2025 · Sep 30, 2024 $1.59
Sga Expense Q3 2025 · Sep 30, 2025 $268.42M
Sga Expense Q3 2025 · Sep 30, 2025 $706.81M
Sga Expense Q3 2025 · Sep 30, 2024 $253.48M
Sga Expense Q3 2025 · Sep 30, 2024 $742.42M
Rd Expense Q3 2025 · Sep 30, 2025 $409.48M
Rd Expense Q3 2025 · Sep 30, 2025 $729.52M
Rd Expense Q3 2025 · Sep 30, 2024 $184.9M
Rd Expense Q3 2025 · Sep 30, 2024 $573.68M
Net Income Q3 2025 · Sep 30, 2025 −$30.74M
Net Income Q3 2025 · Sep 30, 2025 $395.47M
Net Income Q3 2025 · Sep 30, 2024 $106.08M
Net Income Q3 2025 · Sep 30, 2024 $301.92M
Operating Income Q3 2025 · Sep 30, 2025 −$46.69M
Operating Income Q3 2025 · Sep 30, 2025 $454.09M
Operating Income Q3 2025 · Sep 30, 2024 $113.89M
Operating Income Q3 2025 · Sep 30, 2024 $322.81M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $140.09M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $441.73M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $188.46M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $444.1M
Revenue Q3 2025 · Sep 30, 2025 $776.13M
Revenue Q3 2025 · Sep 30, 2025 $2.35B
Revenue Q3 2025 · Sep 30, 2024 $745.74M
Revenue Q3 2025 · Sep 30, 2024 $2.11B